Fair Value Measurements - Additional Information (Detail) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | 9 Months Ended | 3 Months Ended | 1 Months Ended | |||
---|---|---|---|---|---|---|---|
Dec. 31, 2012
|
Dec. 31, 2012
|
Dec. 31, 2012
Contingent Liabilities
|
Sep. 30, 2012
Contingent Liabilities
|
May 31, 2012
Warrant
|
Dec. 31, 2012
Warrant
|
Mar. 31, 2012
Warrant
|
|
Fair Value Inputs, Liabilities, Quantitative Information [Line Items] | |||||||
Fair value of derivative liability | $ 473 | $ 0 | $ 452 | ||||
Expected Life | 5 years | ||||||
Risk free interest rate | 0.40% | ||||||
Dividend yield | 0.00% | ||||||
Volatility | 170.00% | ||||||
Contingent liability | 802 | 802 | 802 | 758 | |||
Loss on fair value of contingent liability | $ 44 | $ 44 | $ 44 |
X | ||||||||||
- Definition
Noncurrent portion of the fair value as of the acquisition date of potential payments under the contingent consideration arrangement, including cash and shares as applicable. No definition available.
|
X | ||||||||||
- Definition
Derivative instrument obligations meeting the definition of a liability which the Company is a party to as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Risk-free interest rate assumption used in valuing an instrument. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The aggregate amount of other expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating expense recognized during the period. Such amounts may include: (a) unusual costs, (b) loss on foreign exchange transactions, (c) losses on securities (net of profits), and (d) miscellaneous other expense items. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|